Metforin Sustained-release Tablets (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Independ Bio Pharmaceutical Co., Ltd.
MFDS item code 201908332 · Approved 2019.12.11
This product's status changed to Expired on 2024.12.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of type 2 diabetes mellitus in adults
This medication is used for the treatment of adult patients with type 2 diabetes who have difficulty controlling blood sugar levels with diet and exercise alone, particularly in overweight individuals. It can be used alone, but may also be combined with other oral hypoglycemic agents or insulin to enhance blood sugar control. This helps to effectively manage blood sugar levels and improve health status.
The dosage should be determined individually based on drug efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual initial dose is 500mg of metformin hydrochloride extended-release tablets once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week. Up to a maximum of 2000mg per day may be administered with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily; both doses should be taken with meals. - In patients already being treated with metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking more than 2000mg of immediate-release metformin tablets per day. - At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess response to treatment with this medicine and identify the minimum effective dose. Blood glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73m2, respectively, administration of this medicine must be discontinued immediately.
This medication can rarely cause a serious condition called lactic acidosis. Lactic acidosis occurs when there is an excessive accumulation of lactic acid in the body, which can be life-threatening if not treated. Care should be taken when using this medication with other hypoglycemic agents, as severe hypoglycemia may occur. This medication should not be used in patients with moderate to severe renal impairment or in acute conditions such as dehydration, severe infection, or heart failure. This medication should be suspended for a period before and after examinations using iodinated contrast agents, and resuming treatment should occur only after confirming normal kidney function. Patients with hypersensitivity to this medication, type 1 diabetes, or diabetic ketoacidosis should not be treated with this medication. Patients in states of tissue hypoxia such as before or after surgery, severe malnutrition, liver dysfunction, or acute myocardial infarction should also avoid using this medication. Caution should be exercised if there are irregular meals, vigorous exercise, or interactions with other medications. While taking this medication, side effects such as vitamin B12 deficiency, gastrointestinal disturbances (nausea, vomiting, diarrhea, etc.), taste alteration, and skin rash may occur. Notably, gastrointestinal disturbances are common during early treatment and can be alleviated by gradually increasing the dose or taking the medication with meals. Kidney function should be regularly assessed, and if significant renal impairment occurs, discontinuation of the medication is needed. Alcohol can increase the risk of side effects from this medication, so excessive drinking should be avoided. During pregnancy, this medication may affect the fetus; hence, pregnant or nursing women should consult with a physician before using it. It is not recommended for children, as safety and efficacy have not been established. Elderly patients should have dosage adjustments made and undergo regular monitoring of kidney function due to common renal impairment. In cases of overdose, hypoglycemia is rare but there is a risk of lactic acidosis; immediate medical attention should be sought, and if necessary, treatments like dialysis should be administered. This medication may interact with other drugs, so be sure to inform your doctor or pharmacist about any other medications you are taking. The tablets should not be crushed or chewed; they must be swallowed whole, and it is normal for the tablet coating to appear in the stool. Regular blood glucose monitoring and kidney function testing during the course of treatment are essential to confirm the efficacy and check for any side effects.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container, protected from air and moisture. To maintain the medication's effectiveness, it is best kept at room temperature, between 1 to 30 degrees Celsius.
White, double-convex, rectangular sustained-release tablet
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Independ Bio Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.